Sigyn Therapeutics Relocates HQ to Beverly Hills
Ticker: SIGY · Form: 8-K · Filed: Jan 30, 2024 · CIK: 1642159
| Field | Detail |
|---|---|
| Company | Sigyn Therapeutics, Inc. (SIGY) |
| Form Type | 8-K |
| Filed Date | Jan 30, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: corporate-governance, administrative-change
TL;DR
**Sigyn Therapeutics moved its HQ to Beverly Hills, signaling potential strategic changes.**
AI Summary
On January 30, 2024, Sigyn Therapeutics, Inc. filed an 8-K to report a change in its principal executive offices from 2468 Historic Decatur Road, Suite 140, San Diego, CA 92106 to 9190 W Olympic Blvd # 263, Beverly Hills, CA 90212. This move signifies a potential shift in operational strategy or a desire for a more prominent location, which could impact investor perception of the company's stability and future growth prospects.
Why It Matters
A change in headquarters can signal a strategic shift, cost-cutting measures, or expansion plans, all of which can influence investor confidence and the company's operational efficiency.
Risk Assessment
Risk Level: low — The filing primarily reports an administrative change of address, which typically carries a low direct risk to investors.
Analyst Insight
Investors should monitor future filings for any strategic announcements or financial impacts related to the change in headquarters, as this administrative change itself doesn't provide direct financial insight.
Key Numbers
- 619-368-2000 — New Business Phone Number (The new contact number for Sigyn Therapeutics, Inc. after the relocation.)
Key Players & Entities
- Sigyn Therapeutics, Inc. (company) — the registrant changing its principal executive offices
- January 30, 2024 (date) — date of earliest event reported and filing date
- 9190 W Olympic Blvd # 263, Beverly Hills, CA 90212 (location) — new principal executive offices address
- 2468 Historic Decatur Road, Suite 140, San Diego, CA 92106 (location) — prior principal executive offices address
- 619-368-2000 (dollar_amount) — new business phone number
Forward-Looking Statements
- The relocation to Beverly Hills may lead to increased operational costs for Sigyn Therapeutics. (Sigyn Therapeutics, Inc.) — medium confidence, target: 2024-12-31
FAQ
What was the previous address of Sigyn Therapeutics, Inc.'s principal executive offices?
The previous address of Sigyn Therapeutics, Inc.'s principal executive offices was 2468 Historic Decatur Road, Suite 140, San Diego, CA 92106.
What is the new address for Sigyn Therapeutics, Inc.'s principal executive offices?
The new address for Sigyn Therapeutics, Inc.'s principal executive offices is 9190 W Olympic Blvd # 263, Beverly Hills, CA 90212.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on January 30, 2024.
What is the new telephone number for Sigyn Therapeutics, Inc.?
The new telephone number for Sigyn Therapeutics, Inc. is 619-368-2000.
Under which item information categories was this 8-K filed?
This 8-K was filed under 'Material Modifications to Rights of Security Holders', 'Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year', and 'Financial Statements and Exhibits'.
Filing Stats: 715 words · 3 min read · ~2 pages · Grade level 11 · Accepted 2024-01-30 16:23:47
Filing Documents
- form8-k.htm (8-K) — 43KB
- ex3-1.htm (EX-3.1) — 1KB
- ex3-1_001.jpg (GRAPHIC) — 375KB
- 0001493152-24-004320.txt ( ) — 728KB
- sigy-20240130.xsd (EX-101.SCH) — 3KB
- sigy-20240130_lab.xml (EX-101.LAB) — 33KB
- sigy-20240130_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. SIGYN THERAPEUTICS, INC. Date: January 30, 2024 By: /s/ James A. Joyce James A. Joyce, Chairman and CEO